Bone turnover markers in patients with inflammatory bowel disease in remission: a cross-sectional comparison of anti-TNFα therapy with conventional maintenance therapy
Our study indicates that patients with IBD are at risk of developing reduced bone mineral density and osteoporosis. While some bone turnover markers appear to normalize during remission, anti-TNF-α treatment does not offer added benefits for bone metabolism compared to conventional therapy.
Authors
- Aneta Sokal (ORCID: https://orcid.org/0000-0003-4727-8766)
- Wiesław Guz (ORCID: https://orcid.org/0000-0002-1309-5374)
- Radosław P. Radzki (ORCID: https://orcid.org/0000-0002-5439-2420)
- Rafał Filip (ORCID: https://orcid.org/0000-0002-5644-6381)
- Sara Jarmakiewicz-Czaja
- D. Piątek
- J. Sztembis
- P. R. Kiela
Institutions
- Medical University of Lublin (PL)
- University of Life Sciences in Lublin (PL)
- Institute for Research and Development (LK)
- Queen's Hospital (GB)
- Associação Saúde da Família (BR)
- Collegium Medicum in Bydgoszcz (PL)
- Children's Center (US)
- University of Rzeszów (PL)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-02-10
- DOI
- https://doi.org/10.3389/fmed.2026.1729584
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00